Protein Description

Gene Symbol HLA-G
Entrez ID 3135
Uniprot ID P17693
Description major histocompatibility complex, class I, G
Chromosomal Location chr6: 29,826,967-29,831,125
Ontology GO ID GO Term Definition Evidence

BP

GO:0002474

antigen processing and presentation of peptide antigen via MHC class I

The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.

TAS

BP

GO:0002479

antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent

The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.

TAS

BP

GO:0002480

antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent

The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.

TAS

BP

GO:0002645

positive regulation of tolerance induction

Any process that activates or increases the frequency, rate, or extent of tolerance induction.

IMP

BP

GO:0002666

positive regulation of T cell tolerance induction

Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction.

IMP

BP

GO:0002767

immune response-inhibiting cell surface receptor signaling pathway

A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell capable of inhibiting an immune response.

IDA

BP

GO:0006968

cellular defense response

A defense response that is mediated by cells.

TAS

BP

GO:0019882

antigen processing and presentation

The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.

IBA

BP

GO:0032735

positive regulation of interleukin-12 production

Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.

IDA

BP

GO:0042130

negative regulation of T cell proliferation

Any process that stops, prevents or reduces the rate or extent of T cell proliferation.

IDA

BP

GO:0045591

positive regulation of regulatory T cell differentiation

Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.

IMP

BP

GO:0050776

regulation of immune response

Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.

TAS

BP

GO:0050777

negative regulation of immune response

Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.

IC

BP

GO:0060333

interferon-gamma-mediated signaling pathway

A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.

TAS

BP

GO:0060337

type I interferon signaling pathway

A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

TAS

BP

GO:2001199

negative regulation of dendritic cell differentiation

Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation.

IDA

CC

GO:0000139

Golgi membrane

The lipid bilayer surrounding any of the compartments of the Golgi apparatus.

TAS

CC

GO:0005886

plasma membrane

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

IBA|TAS

CC

GO:0012507

ER to Golgi transport vesicle membrane

The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi.

TAS

CC

GO:0016020

membrane

A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

IDA

CC

GO:0030670

phagocytic vesicle membrane

The lipid bilayer surrounding a phagocytic vesicle.

TAS

CC

GO:0031901

early endosome membrane

The lipid bilayer surrounding an early endosome.

TAS

CC

GO:0042612

MHC class I protein complex

A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.

IEA

CC

GO:0071556

integral component of lumenal side of endoplasmic reticulum membrane

The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane.

TAS

MF

GO:0003823

antigen binding

Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.

IBA

MF

GO:0005102

receptor binding

Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

IPI

MF

GO:0042803

protein homodimerization activity

Interacting selectively and non-covalently with an identical protein to form a homodimer.

IDA|NAS

Domain ID Description

IPR001039

MHC class I alpha chain, alpha1 alpha2 domains

IPR003006

Immunoglobulin/major histocompatibility complex, conserved site

IPR003597

Immunoglobulin C1-set

IPR007110

Immunoglobulin-like domain

IPR011161

MHC class I-like antigen recognition-like

IPR011162

MHC classes I/II-like antigen recognition protein

IPR013783

Immunoglobulin-like fold

Pathway ID Pathway Term Pathway Source

hsa04144

Endocytosis

KEGG

hsa04145

Phagosome

KEGG

hsa04514

Cell adhesion molecules (CAMs)

KEGG

hsa04612

Antigen processing and presentation

KEGG

hsa04650

Natural killer cell mediated cytotoxicity

KEGG

hsa04940

Type I diabetes mellitus

KEGG

hsa05166

HTLV-I infection

KEGG

hsa05168

Herpes simplex infection

KEGG

hsa05169

Epstein-Barr virus infection

KEGG

hsa05203

Viral carcinogenesis

KEGG

hsa05320

Autoimmune thyroid disease

KEGG

hsa05330

Allograft rejection

KEGG

hsa05332

Graft-versus-host disease

KEGG

hsa05416

Viral myocarditis

KEGG

WP2328

Allograft Rejection

WikiPathways

WP183

Proteasome Degradation

WikiPathways

UMLS CUI UMLS Term

C0004096

Asthma

No tissues found.

No databases found.

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene Symbol Entrez ID Uniprot ID Score

B2M

567

P61769

0.62

HLA-G

3135

P17693

0.89

FAF2

23197

Q96CS3

0.49

KLRD1

3824

Q13241

0.62

HLA-A

3105

P30457

0.63

HLA-C

3107

P30499

0.63

KIR2DL4

3805

Q99706

0.76

TAP1

6890

Q03518

0.83

TAP2

6891

Q03519

0.83

COPB1

1315

P53618

0.84

LILRB2

10288

Q8N423

0.86

CD8A

925

P01732

0.87

LILRB1

10859

Q8NHL6

0.89